LCG
Lisanti Capital Growth Portfolio holdings
AUM
$361M
This Quarter Return
+23.95%
1 Year Return
+138.64%
3 Year Return
+1,060.15%
5 Year Return
+4,097.2%
10 Year Return
+80,447.8%
AUM
$395M
AUM Growth
+$395M
(-5.1%)
Cap. Flow
-$66.1M
Cap. Flow
% of AUM
-16.73%
Top 10 Holdings %
Top 10 Hldgs %
20.23%
Holding
152
New
37
Increased
23
Reduced
52
Closed
36
Top Buys
| 1 |
Zeta Global
ZETA
|
$9.52M |
| 2 |
Meritage Homes
MTH
|
$6.97M |
| 3 |
The Bancorp
TBBK
|
$6.1M |
| 4 |
Inspire Medical Systems
INSP
|
$5.62M |
| 5 |
Klaviyo
KVYO
|
$5.51M |
Top Sells
| 1 |
Credo Technology Group
CRDO
|
$7.79M |
| 2 |
FormFactor
FORM
|
$7.6M |
| 3 |
Weatherford International
WFRD
|
$6.99M |
| 4 |
Camtek
CAMT
|
$5.81M |
| 5 |
Arhaus
ARHS
|
$5.4M |
Sector Composition
| 1 | Industrials | 26.84% |
| 2 | Technology | 24.92% |
| 3 | Healthcare | 23.4% |
| 4 | Consumer Discretionary | 13.64% |
| 5 | Financials | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ollie's Bargain Outlet
OLLI
$7.78B
| $4.98M | 1.26% | 51,280 -42,145 | -45% | -$4.1M |
|
27
Lantheus
LNTH
$3.73B
| $4.91M | 1.24% | 44,740 -33,135 | -43% | -$3.64M |
|
28
Procept Biorobotics
PRCT
$2.23B
| $4.88M | 1.24% | 60,965 -38,275 | -39% | -$3.07M |
|
29
Tandem Diabetes Care
TNDM
$845M
| $4.87M | 1.23% | 114,925 -43,335 | -27% | -$1.84M |
|
30
Semtech
SMTC
$5.04B
| $4.75M | 1.2% | 104,065 +39,110 | +60% | +$1.79M |
|
31
ADMA Biologics
ADMA
$4.12B
| $4.7M | 1.19% | +235,035 | New | +$4.7M |
|
32
BrightSpring Health Services
BTSG
$4.2B
| $4.66M | 1.18% | +317,345 | New | +$4.66M |
|
33
UL Solutions
ULS
$12.7B
| $4.58M | 1.16% | 92,930 -20,685 | -18% | -$1.02M |
|
34
Coherent
COHR
$14.1B
| $4.57M | 1.16% | 51,445 -26,055 | -34% | -$2.32M |
|
35
Dycom Industries
DY
$7.31B
| $4.44M | 1.13% | +22,550 | New | +$4.44M |
|
36
Castle Biosciences
CSTL
$696M
| $4.41M | 1.12% | 154,710 +58,160 | +60% | +$1.66M |
|
37
Transmedics
TMDX
$3.92B
| $4.27M | 1.08% | 27,175 -25,775 | -49% | -$4.05M |
|
38
PACS Group
PACS
$1.81B
| $4.26M | 1.08% | +106,565 | New | +$4.26M |
|
|
ITCI
39
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.25M | 1.08% | 58,115 -24,760 | -30% | -$1.81M |
|
40
Varonis Systems
VRNS
$6.61B
| $4.2M | 1.06% | 74,305 +10,820 | +17% | +$611K |
|
41
Fluor
FLR
$6.63B
| $4M | 1.01% | 83,805 -15,510 | -16% | -$740K |
|
42
Vaxcyte
PCVX
$4B
| $3.72M | 0.94% | 32,515 +13,175 | +68% | +$1.51M |
|
43
LendingTree
TREE
$925M
| $3.65M | 0.92% | +62,910 | New | +$3.65M |
|
44
Western Alliance Bancorporation
WAL
$9.88B
| $3.61M | 0.91% | +41,760 | New | +$3.61M |
|
45
Knife River
KNF
$4.59B
| $3.59M | 0.91% | 40,185 -6,570 | -14% | -$587K |
|
46
Sweetgreen
SG
$1.08B
| $3.55M | 0.9% | 100,205 -47,595 | -32% | -$1.69M |
|
47
SiTime
SITM
$6.28B
| $3.53M | 0.89% | 20,585 -11,650 | -36% | -$2M |
|
48
PAR Technology
PAR
$2.08B
| $3.52M | 0.89% | +67,595 | New | +$3.52M |
|
49
Five Below
FIVE
$8B
| $3.45M | 0.87% | +39,105 | New | +$3.45M |
|
50
RxSight
RXST
$370M
| $3.45M | 0.87% | 69,840 -25,380 | -27% | -$1.25M |
|